Abstract
We have determined the structure, at 2.6 Å resolution, of the AML1 (Runx1) Runt domain–CBFβ–DNA ternary complex, the most common target for mutations in human leukemia. The structure reveals that the Runt domain DNA binding mechanism is unique within the p53 family of transcription factors. The extended C-terminal 'tail' and 'wing' elements adopt a specific DNA-bound conformation that clamps the phosphate backbone between the major and minor grooves of the distorted B-form DNA recognition site. Furthermore, the extended 'tail' mediates most of the NF-κB/Rel-like base-specific contacts in the major groove. The structure clearly explains the molecular basis for the loss of DNA binding function of the Runt domain–CBFβ complex as a consequence of the human disease-associated mutations in leukemogenesis and cleidocranial dysplasia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Accession codes
References
Kagoshima, H. et al. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9, 338–341 (1993).
Speck, N.A. & Stacy, T. In Critical reviews in eukaryotic gene expression. (eds, Stein, G.S., Stein, J. & Lian, J.B.) 337–364 (Begell House, Inc., New York; 1995).
Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321–330 (1996).
Wang, Q. et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87, 697–708 (1996).
Rubnitz, J.E. & Look, A.T. Molecular basis of leukemogenesis. Curr. Opin. Hematol. 5, 264–270 (1998).
Miyoshi, H. et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431–10434 (1991).
Look, A.T. Oncogenic transcription factors in the human acute leukemias. Science 278, 1059–1065 (1997).
Liu, P. et al. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 261, 1041–1044 (1993).
Osato, M. et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias. Blood 93, 1817–1824 (1999).
Preudhomme, C. et al. High incidence of biallelic point mutations in the runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 96, 2862–2869 (2000).
Imai, Y. et al. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 96, 3154–3160 (2000).
Song, W.J. et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia. Nature Genet. 23, 166–175 (1999).
Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755–764 (1997).
Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765–771 (1997).
Mundlos, S. et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773–779 (1997).
Thornell, A., Hallberg, B. & Grundström, T. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65, 42–50 (1991).
Rodan, G.A. & Harada, S. The missing bone. Cell 89, 677–680 (1997).
Goger, M. et al. Molecular insights into PEBP2/CBFβ–SMMHC associated acute leukemia revealed from the structure of PEBP2/CBFβ. Nature Struct. Biol. 6, 620–623 (1999).
Huang, X., Peng, J.W., Speck, N.A. & Bushweller, J.H. Solution structure of core binding factor β and map of the CBFα binding site. Nature Struct. Biol. 6, 624–627 (1999).
Nagata, T. et al. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain. Nature Struct. Biol. 6, 615–619 (1999).
Berardi, M.J. et al. The Ig fold of the core binding factor α Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains. Structure Fold. Des. 7, 1247–1256 (1999).
Warren, A.J., Bravo, J., Williams, R.L. & Rabbitts, T.H. Structural basis for the heterodimeric interaction between the acute leukemia-associated transcription factors AML1 and CBFβ. EMBO J. 19, 3004–3015 (2000).
Murzin, A.G., Brenner, S.E., Hubbard, T. & Chothia, C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247, 536–540 (1995).
Tang, Y.Y. et al. Energetic and functional contribution of residues in the core binding factor β (CBFβ) subunit to heterodimerization with CBFα. J. Biol. Chem. 275, 39579–39588 (2000).
Tang, Y.Y. et al. Biophysical characterization of interactions between the core binding factor α and β subunits and DNA. FEBS Lett. 470, 167–172 (2000).
Nicholls, A., Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281–296 (1991).
Perez-Alvarado, G.C., Munnerlyn, A., Dyson, H.J., Grosschedl, R. & Wright, P.E. Identification of the regions involved in DNA binding by the mouse PEBP2α protein. FEBS Lett. 470, 125–130 (2000).
Nekludova, L. & Pabo, C.O. Distinctive DNA conformation with enlarged major groove is found in Zn− finger–DNA and other protein–DNA complexes. Proc. Natl. Acad. Sci. USA 91, 6948–6952 (1994).
Wolf-Watz, M., Xie, X.Q., Holm, M., Grundström, T. & Härd, T. Solution properties of the free and DNA-bound Runt domain of AML1. Eur. J. Biochem. 261, 251–260 (1999).
Crute, B.E., Lewis, A.F., Wu, Z., Bushweller, J.H. & Speck, N.A. Biochemical and biophysical properties of the core-binding factor α2 (AML1) DNA-binding domain. J. Biol. Chem. 271, 26251–26260 (1996).
Lenny, N., Meyers, S. & Hiebert, S.W. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene 11, 1761–1769 (1995).
Akamatsu, Y., Tsukumo, S., Kagoshima, H., Tsurushita, N. & Shigesada, K. A simple screening for mutant DNA binding proteins: application to murine transcription factor PEBP2α subunit, a founding member of the Runt domain protein family. Gene 185, 111–117 (1997).
Lee, B. et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature Genet. 16, 307–310 (1997).
Cho, Y., Gorina, S., Jeffrey, P.D. & Pavletich, N.P. Crystal structure of a p53 tumor suppressor–DNA complex: understanding tumorigenic mutations. Science 265, 346–355 (1994).
Zhou, G. et al. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet. 8, 2311–2316 (1999).
Quack, I. et al. Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am. J. Hum. Genet. 65, 1268–1278 (1999).
Thornell, A., Hallberg, B. & Grundström, T. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8, 1625–1637 (1988).
Wang, S.W. & Speck, N.A. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12, 89–102 (1992).
Melnikova, I.N., Crute, B.E., Wang, S. & Speck, N.A. Sequence specificity of the core-binding factor. J. Virol. 67, 2408–2411 (1993).
Golling, G., Li, L., Pepling, M., Stebbins, M. & Gergen, J.P. Drosophila homologs of the proto-oncogene product PEBP2/CBFβ regulate the DNA-binding properties of Runt. Mol. Cell. Biol. 16, 932–942 (1996).
Zhang, Y.W. et al. PEBP2αA/CBFA1 mutations in Japanese cleidocranial dysplasia patients. Gene 244, 21–28 (2000).
Werner, M.H., Shigesada, K. & Ito, Y. Runt domains take the lead in hematopoiesis and osteogenesis [news]. Nature Med. 5, 1356–1357 (1999).
Müller, C.W. & Herrmann, B.G. Crystallographic structure of the T domain–DNA complex of the Brachyury transcription factor. Nature 389, 884–888 (1997).
Cramer, P., Varrot, A., Barillas-Mury, C., Kafatos, F.C. & Müller, C.W. Structure of the specificity domain of the Dorsal homologue Gambif1 bound to DNA. Structure Fold. Des. 7, 841–852 (1999).
Müller, C.W. Transcription factors: global and detailed views. Curr. Opin. Struct. Biol. 11, 26–32 (2001).
Leslie, A.G.W. Recent changes to the MOSFLM package for film and image plate data. in Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography 26 (Daresbury Laboratory, Warrington, UK; 1992).
CCP4. Collaborative Computing Project 4: A suite of programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
Brünger, A.T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Schiestl, R.H. & Gietz, R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16, 339–346 (1989).
Esnouf, RM. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr. D 55, 938–940 (1999).
Kraulis, P.J. A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946–950 (1991).
Chen, Y.Q., Sengchanthalangsy, L.L., Hackett, A. & Ghosh, G. NF-κB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets. Structure Fold. Des. 8, 419–428 (2000).
Chen, L., Glover, J.N., Hogan, P.G., Rao, A. & Harrison, S.C. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392, 42–48 (1998).
Lu, X.J., Shakked, Z. & Olson, W.K. A-form conformational motifs in ligand-bound DNA structures. J. Mol. Biol. 300, 819–840 (2000).
Acknowledgements
We thank S. Arzt for help with data collection at ESRF beamline ID14-3; R. Williams for invaluable assistance; S.A. Islam and M.J.E. Sternberg (ICRF) for the program PREPI; J. Bushweller and H. Kanegane for sharing unpublished data; C. Müller for the preprint of his review; D. Rhodes, A. Murzin, D. Neuhaus and A. Travers for helpful discussions. A.J.W. is supported by an MRC Senior Clinical Fellowship. N.A.S. is supported by Public Health Service grants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bravo, J., Li, Z., Speck, N. et al. The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp. Nat Struct Mol Biol 8, 371–378 (2001). https://doi.org/10.1038/86264
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/86264
This article is cited by
-
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
Communications Biology (2023)
-
Control of focal adhesion kinase activation by RUNX1-regulated miRNAs in high-risk AML
Leukemia (2023)
-
Selective deployment of transcription factor paralogs with submaximal strength facilitates gene regulation in the immune system
Nature Immunology (2019)
-
Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML
Leukemia (2018)
-
Identifying Druggable Targets by Protein Microenvironments Matching: Application to Transcription Factors
CPT: Pharmacometrics & Systems Pharmacology (2014)


